• Aumenta el tamaño del texto
  • Disminuye el tamaño del texto
  • Imprimir
  • Send

IRB Barcelona in the media

Discovery of an AIDS drug that attacks the herpesvirus

12 October 2010

Cordis, the internet gateway to Research and Development in the European Union, echoes the work performed by Miquel Coll, coordinator of the Computational and Structural Biology programme. Coll's research, which is partly funded by the European Union as part of SPINE2-COMPLEXES project within the Sixth Framework Programme, presents encouraging results with regards herpes viruses. This family of viruses is the cause of many diseases, such as cold sores, genital herpes, chickenpox, etc., and the most recent study published by these researchers at IRB Barcelona suggests that these viruses could be treated with a drug for AIDS that is already on the market.



News search

News search

Press Office

  • Sònia Armengou
    Media relations
    Tel:+34 93 403 72 55
    Fax:+34 93 403 71 14
    sonia.armengouarrobairbbarcelona.org
  • Generalitat de catalunya
  • Generalitat de catalunya. Salut
  • Universidad de Barcelona
  • Parc cientific

Institute for Research in Biomedicine (IRB Barcelona)
Parc Científic de Barcelona
C/ Baldiri Reixac 10
08028 Barcelona - Spain
Tel: +34 93 402 02 50 | Fax: +34 93 403 71 14
infoarrobairbbarcelona.org